174 related articles for article (PubMed ID: 28844983)
1. Structural features of human DJ-1 in distinct Cys106 oxidative states and their relevance to its loss of function in disease.
Kiss R; Zhu M; Jójárt B; Czajlik A; Solti K; Fórizs B; Nagy É; Zsila F; Beke-Somfai T; Tóth G
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt A):2619-2629. PubMed ID: 28844983
[TBL] [Abstract][Full Text] [Related]
2. The effect of cysteine oxidation on DJ-1 cytoprotective function in human alveolar type II cells.
Bahmed K; Boukhenouna S; Karim L; Andrews T; Lin J; Powers R; Wilson MA; Lin CR; Messier E; Reisdorph N; Powell RL; Tang HY; Mason RJ; Criner GJ; Kosmider B
Cell Death Dis; 2019 Sep; 10(9):638. PubMed ID: 31474749
[TBL] [Abstract][Full Text] [Related]
3. Stepwise oxidations play key roles in the structural and functional regulations of DJ-1.
Song IK; Kim MS; Ferrell JE; Shin DH; Lee KJ
Biochem J; 2021 Oct; 478(19):3505-3525. PubMed ID: 34515295
[TBL] [Abstract][Full Text] [Related]
4. Backbone resonance assignment of human DJ-1 in the reduced state and in the cysteine sulfinic acid state.
Barbieri L; Luchinat E
Biomol NMR Assign; 2019 Oct; 13(2):371-376. PubMed ID: 31377986
[TBL] [Abstract][Full Text] [Related]
5. Use of cysteine-reactive cross-linkers to probe conformational flexibility of human DJ-1 demonstrates that Glu18 mutations are dimers.
Prahlad J; Hauser DN; Milkovic NM; Cookson MR; Wilson MA
J Neurochem; 2014 Sep; 130(6):839-53. PubMed ID: 24832775
[TBL] [Abstract][Full Text] [Related]
6. Formation of a stabilized cysteine sulfinic acid is critical for the mitochondrial function of the parkinsonism protein DJ-1.
Blackinton J; Lakshminarasimhan M; Thomas KJ; Ahmad R; Greggio E; Raza AS; Cookson MR; Wilson MA
J Biol Chem; 2009 Mar; 284(10):6476-85. PubMed ID: 19124468
[TBL] [Abstract][Full Text] [Related]
7. DJ-1 as a Biomarker of Parkinson's Disease.
Saito Y
Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
[TBL] [Abstract][Full Text] [Related]
8. The oxidation state of DJ-1 regulates its chaperone activity toward alpha-synuclein.
Zhou W; Zhu M; Wilson MA; Petsko GA; Fink AL
J Mol Biol; 2006 Mar; 356(4):1036-48. PubMed ID: 16403519
[TBL] [Abstract][Full Text] [Related]
9. Oxidative inactivation of the endogenous antioxidant protein DJ-1 by the food contaminants 3-MCPD and 2-MCPD.
Buhrke T; Voss L; Briese A; Stephanowitz H; Krause E; Braeuning A; Lampen A
Arch Toxicol; 2018 Jan; 92(1):289-299. PubMed ID: 28707023
[TBL] [Abstract][Full Text] [Related]
10. Roles of distinct cysteine residues in S-nitrosylation and dimerization of DJ-1.
Ito G; Ariga H; Nakagawa Y; Iwatsubo T
Biochem Biophys Res Commun; 2006 Jan; 339(2):667-72. PubMed ID: 16316629
[TBL] [Abstract][Full Text] [Related]
11. Structural Biology of the DJ-1 Superfamily.
Smith N; Wilson MA
Adv Exp Med Biol; 2017; 1037():5-24. PubMed ID: 29147900
[TBL] [Abstract][Full Text] [Related]
12. Discovery and Optimization of Inhibitors of the Parkinson's Disease Associated Protein DJ-1.
Tashiro S; Caaveiro JMM; Nakakido M; Tanabe A; Nagatoishi S; Tamura Y; Matsuda N; Liu D; Hoang QQ; Tsumoto K
ACS Chem Biol; 2018 Sep; 13(9):2783-2793. PubMed ID: 30063823
[TBL] [Abstract][Full Text] [Related]
13. Novel Redox-Dependent Esterase Activity (EC 3.1.1.2) for DJ-1: Implications for Parkinson's Disease.
Vázquez-Mayorga E; Díaz-Sánchez ÁG; Dagda RK; Domínguez-Solís CA; Dagda RY; Coronado-Ramírez CK; Martínez-Martínez A
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556455
[TBL] [Abstract][Full Text] [Related]
14. The role of cysteine oxidation in DJ-1 function and dysfunction.
Wilson MA
Antioxid Redox Signal; 2011 Jul; 15(1):111-22. PubMed ID: 20812780
[TBL] [Abstract][Full Text] [Related]
15. Distribution of oxidized DJ-1 in Parkinson's disease-related sites in the brain and in the peripheral tissues: effects of aging and a neurotoxin.
Mita Y; Kataoka Y; Saito Y; Kashi T; Hayashi K; Iwasaki A; Imanishi T; Miyasaka T; Noguchi N
Sci Rep; 2018 Aug; 8(1):12056. PubMed ID: 30104666
[TBL] [Abstract][Full Text] [Related]
16. Expression of DJ-1 in Neurodegenerative Disorders.
Antipova D; Bandopadhyay R
Adv Exp Med Biol; 2017; 1037():25-43. PubMed ID: 29147901
[TBL] [Abstract][Full Text] [Related]
17. Identification of an artificial peptide motif that binds and stabilizes reduced human DJ-1.
Premkumar L; Dobaczewska MK; Riedl SJ
J Struct Biol; 2011 Dec; 176(3):414-8. PubMed ID: 21893204
[TBL] [Abstract][Full Text] [Related]
18. Destabilization of DJ-1 by familial substitution and oxidative modifications: implications for Parkinson's disease.
Hulleman JD; Mirzaei H; Guigard E; Taylor KL; Ray SS; Kay CM; Regnier FE; Rochet JC
Biochemistry; 2007 May; 46(19):5776-89. PubMed ID: 17451229
[TBL] [Abstract][Full Text] [Related]
19. Separation of native and C106-oxidized DJ-1 proteins by using column chromatography.
Choi J; Yoo HJ; Cho K; Kim HN; Lee JH; Ryu KS
Protein Expr Purif; 2022 Aug; 195-196():106092. PubMed ID: 35430350
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease-related DJ-1 modulates the expression of uncoupling protein 4 against oxidative stress.
Xu S; Yang X; Qian Y; Xiao Q
J Neurochem; 2018 May; 145(4):312-322. PubMed ID: 29315581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
